Biotech Values

[tinkershaw]

Here is my issue with NBIX, WHERE THE HECK IS THE INSIDER BUYING!!! They have this drug, elagolix, that works, potentially a billion + market, late stage 2, actively seeking partners and the company has a market value of $88 billion, with over $50 million in cash. You could pick it up for $30 million for a potential billion drug that is in late phase II.

YEEEETTTTT, no insider buying.

Would not you be buying at this absurdly cheap price if you had any confidence at all that this drug was the real thing?

I can read the science like anyone else, but there are limitations to what we can know. So I also like to look for other clues. NO INSIDER BUYING! Don't tell me it is just because they have so many stock options to begin with (which is absurdly true with NBIX).

One or two insider buys in NBIX would rally the share price and provide great confidence. The lack thereof is like a scream of No! to me, in the present circumstances of the stock.

Tinker